Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP160679.RAH1oxQJ4wWRVHtZGaxD-CRhkNnqFdV4AHKjys2OdoXyo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP160679.RAH1oxQJ4wWRVHtZGaxD-CRhkNnqFdV4AHKjys2OdoXyo130_assertion type Assertion NP160679.RAH1oxQJ4wWRVHtZGaxD-CRhkNnqFdV4AHKjys2OdoXyo130_head.
- NP160679.RAH1oxQJ4wWRVHtZGaxD-CRhkNnqFdV4AHKjys2OdoXyo130_assertion description "[Adoptive transfer of chimeric antigen receptor (CAR)-expressing T cells is a promising new therapy for hematologic malignancies, but an ideal target antigen for CAR-expressing T-cell therapies for multiple myeloma has not been identified.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP160679.RAH1oxQJ4wWRVHtZGaxD-CRhkNnqFdV4AHKjys2OdoXyo130_provenance.
- NP160679.RAH1oxQJ4wWRVHtZGaxD-CRhkNnqFdV4AHKjys2OdoXyo130_assertion evidence source_evidence_literature NP160679.RAH1oxQJ4wWRVHtZGaxD-CRhkNnqFdV4AHKjys2OdoXyo130_provenance.
- NP160679.RAH1oxQJ4wWRVHtZGaxD-CRhkNnqFdV4AHKjys2OdoXyo130_assertion SIO_000772 23344265 NP160679.RAH1oxQJ4wWRVHtZGaxD-CRhkNnqFdV4AHKjys2OdoXyo130_provenance.
- NP160679.RAH1oxQJ4wWRVHtZGaxD-CRhkNnqFdV4AHKjys2OdoXyo130_assertion wasDerivedFrom befree-20140225 NP160679.RAH1oxQJ4wWRVHtZGaxD-CRhkNnqFdV4AHKjys2OdoXyo130_provenance.
- NP160679.RAH1oxQJ4wWRVHtZGaxD-CRhkNnqFdV4AHKjys2OdoXyo130_assertion wasGeneratedBy ECO_0000203 NP160679.RAH1oxQJ4wWRVHtZGaxD-CRhkNnqFdV4AHKjys2OdoXyo130_provenance.